Aurora Cannabis Inc (ACB.TO) saw its stock price drop by 4.13% in the last trading session, closing at CA$3.95.
This decline reflects ongoing concerns among investors, even though the company recently reported positive revenue figures. With a market cap of about CA$249.9 million, Aurora's performance raises questions about its future in the competitive cannabis market.
Advertisement
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeAdvertisement
Market cap
$249.63M
52W high
$9.33
52W low
$3.59
1W change
+28.64%
Beta
1.34
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 10.5% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.56
+10.5% Upside
Current Price
C$5.03
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
73.2%
Annualized
90-Day Vol
60.5%
Annualized
Trend (90d)
+37.5%
Annualized drift
90d Mean
C$5.75
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$5.26 | C$4.09 – C$6.77 |
| 60 trading days | C$5.50 | C$3.85 – C$7.86 |
| 90 trading days | C$5.75 | C$3.71 – C$8.91 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious about Aurora Cannabis Inc's recent stock decline and consider the broader implications of its financial performance and market sentiment.
Aurora Cannabis Inc's stock drops 4.13% in one day.
Despite achieving record revenues, Aurora's stock price shows uncertainty in the cannabis market, with investors reacting to broader economic factors.
Bull case
Aurora recently announced record annual global medical cannabis net revenue of CA$288.6 million, which is an 18% increase from last year. This indicates strong demand in its sector.
Bear case
The stock's drop today highlights investor skepticism, likely due to concerns about profitability, as shown by a negative profit margin of -42.41%.
Market Reaction to Aurora's Performance
Advertisement
The 4.13% drop in Aurora's stock price comes despite the company announcing record annual revenues. Investors seem to be weighing these positive financial results against ongoing worries about profitability and market competition.
Understanding the Cannabis Market Landscape
Aurora operates in a highly competitive cannabis market, where stock price fluctuations can be influenced by broader economic factors and regulatory changes. Investors are encouraged to stay informed about market trends that could impact Aurora's performance.
Looking Ahead: What’s Next for ACB.TO?
As Aurora prepares for its upcoming investor conference call, stakeholders will be eager to hear insights on future strategies and how the company plans to navigate the challenges it faces in the cannabis industry.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
